Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 7 most recent Form 4 transactions.
| Jul 1, 2025 | INZY | Inozyme Pharma, Inc. | DTOISS◆ | 135,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 1, 2025 | INZY | Inozyme Pharma, Inc. | DTOISS◆ | 180,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 1, 2025 | INZY | Inozyme Pharma, Inc. | DTOISS◆ | 38,500 | — | — | — | Open the original filing on SEC.gov |
| Jul 1, 2025 | INZY | Inozyme Pharma, Inc. | UTENDR | 39,701 | $4.00 | $158.8K | -100.0% | Open the original filing on SEC.gov |
| Jun 25, 2025 | INZY | Inozyme Pharma, Inc. | AGRANT | 6,813 | $0.74 | $5K | +20.7% | Open the original filing on SEC.gov |